Search Results - "MCPHERSON, Stuart"

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management by McPherson, Stuart, Hardy, Tim, Henderson, Elsbeth, Burt, Alastair D, Day, Christopher P, Anstee, Quentin M

“…Graphical abstract…”
Get full text

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis by McPherson, Stuart, Hardy, Tim, Dufour, Jean-Francois, Petta, Salvatore, Romero-Gomez, Manuel, Allison, Mike, Oliveira, Claudia P, Francque, Sven, Van Gaal, Luc, Schattenberg, Jörn M, Tiniakos, Dina, Burt, Alastair, Bugianesi, Elisabetta, Ratziu, Vlad, Day, Christopher P, Anstee, Quentin M

“…Non-invasive fibrosis scores are widely used to identify/exclude advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). However, these…”
Get full text

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease by Hardy, Timothy, Zeybel, Mujdat, Day, Christopher P, Dipper, Christian, Masson, Steven, McPherson, Stuart, Henderson, Elsbeth, Tiniakos, Dina, White, Steve, French, Jeremy, Mann, Derek A, Anstee, Quentin M, Mann, Jelena

“…Liver biopsy is currently the most reliable way of evaluating liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Its inherent risks…”
Get more information

What is the impact of a Hepatitis C 'test, trace and treat' pilot using peer workers? by Caroline, Allsop, Kate, Mcque, Roberts, Mark, Ryan, Jelley, Murphy, Suzanne, Richardson, Carrie, Coyte, Aishah, Taha, Yusri, Stuart, McPherson

“…Chronic Hepatitis C virus (HCV) infection is a major cause of morbidity and deaths worldwide. HCV treating teams are working toward the goal of eliminating HCV…”
Get full text

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging by Dyson, Jessica K, Anstee, Quentin M, McPherson, Stuart

“…Non-alcoholic fatty liver disease (NAFLD) is now the commonest cause of abnormal liver function tests (LFTs) in the UK with approximately a third of the…”
Get full text

Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation by McPherson, Stuart, Elsharkawy, Ahmed M., Ankcorn, Michael, Ijaz, Samreen, Powell, James, Rowe, Ian, Tedder, Richard, Andrews, Peter A.

“…ABSTRACTThe incidence and prevalence of hepatitis E virus (HEV) infection has increased in many developed countries over the last decade, predominantly due to…”
Get full text

Reply to “Liver failure in human immunodeficiency virus – Hepatitis C virus coinfection treated with sofosbuvir, ledipasvir and antiretroviral therapy” by Dyson, Jessica K, McPherson, Stuart

Get full text

Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study by Hallsworth, Kate, Dombrowski, Stephan U, McPherson, Stuart, Anstee, Quentin M, Avery, Leah

“…Healthcare professionals and patients highlighted a need to increase knowledge about what NAFLD is and how to manage it through lifestyle behaviour change…”
Get full text

Feasibility and acceptability of an evidence-informed digital intervention to support self-management in people with non-alcoholic fatty liver disease: protocol for a non-randomised feasibility study (VITALISE) by Avery, Leah, Smith, Hollie, McPherson, Stuart, Hallsworth, Kate

“…Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of disease ranging from simple fatty liver to non-alcoholic steatohepatitis, cirrhosis, liver…”
Get full text

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis by McPherson, Stuart, Wilkinson, Nina, Tiniakos, Dina, Wilkinson, Jennifer, Burt, Alastair D, McColl, Elaine, Stocken, Deborah D, Steen, Nick, Barnes, Jane, Goudie, Nicola, Stewart, Stephen, Bury, Yvonne, Mann, Derek, Anstee, Quentin M, Day, Christopher P

“…Non-alcoholic fatty liver disease (NAFLD) is a common liver disease worldwide. Experimental and small clinical trials have demonstrated that angiotensin II…”
Get full text

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease by Boyle, Marie, Tiniakos, Dina, Schattenberg, Jorn M, Ratziu, Vlad, Bugianessi, Elisabetta, Petta, Salvatore, Oliveira, Claudia P, Govaere, Olivier, Younes, Ramy, McPherson, Stuart, Bedossa, Pierre, Nielsen, Mette J, Karsdal, Morten, Leeming, Diana, Kendrick, Stuart, Anstee, Quentin M

“…There is an unmet need for non-invasive biomarkers in non-alcoholic fatty liver disease (NAFLD) that can diagnose advanced disease and identify patients…”
Get full text

Clinical performance of Determine HBsAg 2 rapid test for Hepatitis B detection by Avellon, Ana, Ala, Aftab, Diaz, Antonio, Domingo, Daniel, Gonzalez, Rosario, Hidalgo, Lorena, Kooner, Paul, Loganathan, Sabarinathan, Martin, Dolores, McPherson, Stuart, Munoz‐Chimeno, Milagros, Ryder, Stephen, Slapak, Gabrielle, Ryan, Pablo, Valbuena, Marta, Kennedy, Patrick T.

“…Hepatitis B virus (HBV) infection is estimated to affect 292 million people worldwide, 90% of them are unaware of their HBV status. The Determine HBsAg 2…”
Get full text

Embedding assessment of liver fibrosis into routine diabetic review in primary care by Mansour, Dina, Grapes, Allison, Herscovitz, Marc, Cassidy, Paul, Vernazza, Jonathan, Broad, Andrea, Anstee, Quentin M., McPherson, Stuart

“…Individuals with type 2 diabetes (T2DM) are at high risk of developing non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis/cirrhosis. Screening…”
Get full text

Nutrigenetics-based intervention approach for adults with non-alcoholic fatty liver disease (NAFLD): study protocol for a randomised controlled feasibility trial by Haigh, Laura, McPherson, Stuart, Mathers, John C, Anstee, Quentin M

“…IntroductionLifestyle interventions targeting weight loss and improved dietary patterns are the recommended treatment for non-alcoholic fatty liver disease…”
Get full text

Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus by Sy, Aminata, McCabe, Leanne, Hudson, Emma, Ansari, Azim M, Pedergnana, Vincent, Lin, Shang-Kuan, Santana, S, Fiorino, Marzia, Ala, Aftab, Stone, Ben, Smith, M, Nelson, Mark, Barclay, Stephen T, McPherson, Stuart, Ryder, Stephen D, Collier, Jane, Barnes, Eleanor, Walker, Ann Sarah, Pett, Sarah L, Cooke, Graham

“…The CC genotype of the IFNL4 gene is known to be associated with increased Hepatitis C (HCV) cure rates with interferon-based therapy and may contribute to…”
Get full text

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered by McPherson, Stuart, Jonsson, Julie R, Cowin, Gary J, O’Rourke, Peter, Clouston, Andrew D, Volp, Andrew, Horsfall, Leigh, Jothimani, Dinesh, Fawcett, Jonathan, Galloway, Graham J, Benson, Mark, Powell, Elizabeth E

“…Background/Aims Currently the diagnosis and severity of hepatic steatosis can be established accurately only by liver biopsy. Previous small studies found that…”
Get full text

Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection by Gallacher, Jennifer, Taha, Yusri, da Silva Filipe, Ana, Ijaz, Samreen, McPherson, Stuart

“…Persistent Hepatitis E Virus infection (HEV) is a rare but increasingly recognised condition in immunocompromised individuals. Untreated, this infection can…”
Get full text

Intravenous Immunoglobulin for the Treatment of Severe, Refractory, and Recurrent Clostridium difficile Diarrhea by McPherson, Stuart, Rees, Colin J, Ellis, Richard, Soo, Shelly, Panter, Simon J

“…PURPOSE:Clostridium difficile diarrhea is common in elderly patients and leads to prolonged hospitalization. Patients with severe or recurrent Clostridium…”
Get full text

ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis—study protocol for an interventional randomised controlled trial by Crocombe, Dominic, Ahmed, Norin, Balakrishnan, Indran, Bordea, Ekaterina, Chau, Marisa, China, Louise, Corless, Lynsey, Danquah, Victoria, Dehbi, Hakim-Moulay, Dillon, John F, Forrest, Ewan H, Freemantle, Nick, Gear, David Peter, Hollywood, Coral, Hunter, Rachael, Jeyapalan, Tasheeka, Kallis, Yiannis, McPherson, Stuart, Munteanu, Iulia, Portal, Jim, Richardson, Paul, Ryder, Stephen D, Virk, Amandeep, Wright, Gavin, O'Brien, Alastair

“…Background Bacterial infection is a major cause of mortality in patients with cirrhosis. Spontaneous bacterial peritonitis (SBP) is a serious and common…”
Get full text

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review by Gallacher, Jennifer, McPherson, Stuart

“…As the rates of obesity increase worldwide, the prevalence of nonalcoholic fatty liver disease (NAFLD) has risen and it is now the most common cause of liver…”
Get full text